165 related articles for article (PubMed ID: 12470805)
1. Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities.
Blass JP
Neurobiol Aging; 2002; 23(6):1077-84. PubMed ID: 12470805
[TBL] [Abstract][Full Text] [Related]
2. Abeta conformational change is central to Alzheimer's disease.
Holtzman DM
Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806
[No Abstract] [Full Text] [Related]
3. Testing times for the "amyloid cascade hypothesis".
Hardy J
Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803
[No Abstract] [Full Text] [Related]
4. Amyloid-beta: a (life) preserver for the brain.
Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA
Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809
[No Abstract] [Full Text] [Related]
5. Bioflocculant hypothesis: a partial endorsement.
Terry R
Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804
[No Abstract] [Full Text] [Related]
6. Evolution and the scientific method.
Tucker HM; Estus S
Neurobiol Aging; 2002; 23(6):1093-5. PubMed ID: 12470808
[No Abstract] [Full Text] [Related]
7. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.
Robinson SR; Bishop GM
Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802
[TBL] [Abstract][Full Text] [Related]
8. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions?
Savory J; Ghribi O; Herman MM
Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807
[No Abstract] [Full Text] [Related]
9. The amyloid hypothesis: let sleeping dogmas lie?
Bishop GM; Robinson SR
Neurobiol Aging; 2002; 23(6):1101-5. PubMed ID: 12470810
[TBL] [Abstract][Full Text] [Related]
10. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
11. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
Gandy S; Petanceska S
Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
[TBL] [Abstract][Full Text] [Related]
13. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
[TBL] [Abstract][Full Text] [Related]
14. Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.
Huichalaf CH; Al-Ramahi I; Park KW; Grunke SD; Lu N; de Haro M; El-Zein K; Gallego-Flores T; Perez AM; Jung SY; Botas J; Zoghbi HY; Jankowsky JL
Hum Mol Genet; 2019 Jun; 28(12):2014-2029. PubMed ID: 30753434
[TBL] [Abstract][Full Text] [Related]
15. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
17. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
[TBL] [Abstract][Full Text] [Related]
18. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
19. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
[TBL] [Abstract][Full Text] [Related]
20. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
van Groen T; Liu L; Ikonen S; Kadish I
Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]